These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 35061326)
21. Urinary exosome miR-30c-5p as a biomarker of clear cell renal cell carcinoma that inhibits progression by targeting HSPA5. Song S; Long M; Yu G; Cheng Y; Yang Q; Liu J; Wang Y; Sheng J; Wang L; Wang Z; Xu B J Cell Mol Med; 2019 Oct; 23(10):6755-6765. PubMed ID: 31342628 [TBL] [Abstract][Full Text] [Related]
22. Androgen receptor modulates metastatic routes of VHL wild-type clear cell renal cell carcinoma in an oxygen-dependent manner. Huang Q; Sun Y; Zhai W; Ma X; Shen D; Du S; You B; Niu Y; Huang CP; Zhang X; Chang C Oncogene; 2020 Oct; 39(43):6677-6691. PubMed ID: 32943729 [TBL] [Abstract][Full Text] [Related]
23. LncRNA ITGB2-AS1 promotes the progression of clear cell renal cell carcinoma by modulating miR-328-5p/HMGA1 axis. Zhang W; Lu Y; Shi H; Li X; Zhang Z; Deng X; Yang Y; Wan B Hum Cell; 2021 Sep; 34(5):1545-1557. PubMed ID: 34170494 [TBL] [Abstract][Full Text] [Related]
24. Circ-AKT3 inhibits clear cell renal cell carcinoma metastasis via altering miR-296-3p/E-cadherin signals. Xue D; Wang H; Chen Y; Shen D; Lu J; Wang M; Zebibula A; Xu L; Wu H; Li G; Xia L Mol Cancer; 2019 Nov; 18(1):151. PubMed ID: 31672157 [TBL] [Abstract][Full Text] [Related]
26. Inhibition of miR-34a-5p can rescue disruption of the p53-DAPK axis to suppress progression of clear cell renal cell carcinoma. Jing ZF; Bi JB; Li Z; Liu X; Li J; Zhu Y; Zhang XT; Zhang Z; Li Z; Kong CZ Mol Oncol; 2019 Oct; 13(10):2079-2097. PubMed ID: 31294899 [TBL] [Abstract][Full Text] [Related]
27. Long non-coding RNA ZFAS1 promotes proliferation and metastasis of clear cell renal cell carcinoma via targeting miR-10a/SKA1 pathway. Dong D; Mu Z; Wei N; Sun M; Wang W; Xin N; Shao Y; Zhao C Biomed Pharmacother; 2019 Mar; 111():917-925. PubMed ID: 30841471 [TBL] [Abstract][Full Text] [Related]
28. MicroRNA Expression Profiling in Clear Cell Renal Cell Carcinoma: Identification and Functional Validation of Key miRNAs. He H; Wang L; Zhou W; Zhang Z; Wang L; Xu S; Wang D; Dong J; Tang C; Tang H; Yi X; Ge J PLoS One; 2015; 10(5):e0125672. PubMed ID: 25938468 [TBL] [Abstract][Full Text] [Related]
29. FOXM1-Activated LINC01094 Promotes Clear Cell Renal Cell Carcinoma Development via MicroRNA 224-5p/CHSY1. Jiang Y; Zhang H; Li W; Yan Y; Yao X; Gu W Mol Cell Biol; 2020 Jan; 40(3):. PubMed ID: 31767633 [TBL] [Abstract][Full Text] [Related]
30. MiR-212-5p inhibits the malignant behavior of clear cell renal cell carcinoma cells by targeting TBX15. Deng JH; Zheng GY; Li HZ; Ji ZG Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10699-10707. PubMed ID: 31858538 [TBL] [Abstract][Full Text] [Related]
31. The long non-coding RNA NNT-AS1 promotes clear cell renal cell carcinoma progression via regulation of the miR-137/ Y-box binding protein 1 axis. Zhou Y; Zhang Z; Wo M; Xu W Bioengineered; 2021 Dec; 12(1):8994-9005. PubMed ID: 34643163 [TBL] [Abstract][Full Text] [Related]
32. MicroRNA-30a-5p Inhibits the Growth of Renal Cell Carcinoma by Modulating GRP78 Expression. Wang C; Cai L; Liu J; Wang G; Li H; Wang X; Xu W; Ren M; Feng L; Liu P; Zhang C Cell Physiol Biochem; 2017; 43(6):2405-2419. PubMed ID: 29073630 [TBL] [Abstract][Full Text] [Related]
33. Sulforaphane inhibits cancer stem-like cell properties and cisplatin resistance through miR-214-mediated downregulation of c-MYC in non-small cell lung cancer. Li QQ; Xie YK; Wu Y; Li LL; Liu Y; Miao XB; Liu QZ; Yao KT; Xiao GH Oncotarget; 2017 Feb; 8(7):12067-12080. PubMed ID: 28076844 [TBL] [Abstract][Full Text] [Related]
34. MicroRNAs MiR-15a and MiR-26a cooperatively regulate O-GlcNAc-transferase to control proliferation in clear cell renal cell carcinoma. Kalantzakos TJ; Sullivan TB; Sebel LE; Canes D; Burks EJ; Moinzadeh A; Rieger-Christ KM Cancer Biomark; 2021; 30(3):343-351. PubMed ID: 33337348 [TBL] [Abstract][Full Text] [Related]
35. Targeting the ERβ/Angiopoietin-2/Tie-2 signaling-mediated angiogenesis with the FDA-approved anti-estrogen Faslodex to increase the Sunitinib sensitivity in RCC. Gu J; Zhang Y; Han Z; Gao L; Cui J; Sun Y; Niu Y; You B; Huang CP; Chang C; Wang X; Yeh S Cell Death Dis; 2020 May; 11(5):367. PubMed ID: 32409702 [TBL] [Abstract][Full Text] [Related]
36. HMGA1-mediated miR-671-5p targets APC to promote metastasis of clear cell renal cell carcinoma through Wnt signaling. Chi XG; Meng XX; Ding DL; Xuan XH; Chen YZ; Cai Q; Wang A Neoplasma; 2020 Jan; 67(1):46-53. PubMed ID: 31686521 [TBL] [Abstract][Full Text] [Related]
37. Liu Q; Lei C Ann Med; 2021 Dec; 53(1):2153-2164. PubMed ID: 34783622 [TBL] [Abstract][Full Text] [Related]
39. CD103-positive CSC exosome promotes EMT of clear cell renal cell carcinoma: role of remote MiR-19b-3p. Wang L; Yang G; Zhao D; Wang J; Bai Y; Peng Q; Wang H; Fang R; Chen G; Wang Z; Wang K; Li G; Yang Y; Wang Z; Guo P; Peng L; Hou D; Xu W Mol Cancer; 2019 Apr; 18(1):86. PubMed ID: 30975145 [TBL] [Abstract][Full Text] [Related]
40. Construction of circRNA-based ceRNA network to reveal the role of circRNAs in the progression and prognosis of metastatic clear cell renal cell carcinoma. Wei X; Dong Y; Chen X; Ren X; Li G; Wang Y; Wang Y; Zhang T; Wang S; Qin C; Song N Aging (Albany NY); 2020 Nov; 12(23):24184-24207. PubMed ID: 33223511 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]